Related references
Note: Only part of the references are listed.Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations
Annika Schaefer et al.
EXPERIMENTAL DERMATOLOGY (2013)
A New Series of Small Molecular Weight Compounds Induce Read Through of All Three Types of Nonsense Mutations in the ATM Gene
Liutao Du et al.
MOLECULAR THERAPY (2013)
SMRT compounds correct nonsense mutations in primary immunodeficiency and other genetic models
Richard A. Gatti
YEAR IN HUMAN AND MEDICAL GENETICS: INBORN ERRORS OF IMMUNITY III (2012)
Shining a Light on Xeroderma Pigmentosum
John J. DiGiovanna et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Pharmaceutical therapies to recode nonsense mutations in inherited diseases
Hui-Ling Rose Lee et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
M. Wilschanski et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair
Porcia T. Bradford et al.
JOURNAL OF MEDICAL GENETICS (2011)
Diagnosing Xeroderma Pigmentosum Group C by Immunohistochemistry
Sebastien de Feraudy et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2010)
In vitro readthrough of termination codons by gentamycin in the Stuve-Wiedemann Syndrome
Samuel Bellais et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2010)
XPC Branch-Point Sequence Mutations Disrupt U2 snRNP Binding, Resulting in Abnormal pre-mRNA Splicing in Xeroderma Pigmentosum Patients
Sikandar G. Khan et al.
HUMAN MUTATION (2010)
Transdermal delivery of a readthrough-inducing drug: a new approach of gentamicin administration for the treatment of nonsense mutation-mediated disorders
Masataka Shiozuka et al.
JOURNAL OF BIOCHEMISTRY (2010)
A Prevalent Mutation with Founder Effect in Xeroderma Pigmentosum Group C from North Africa
Nadem Soufir et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Dynamic two-stage mechanism of versatile DNA damage recognition by xeroderma pigmentosum group C protein
Flurina C. Clement et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2010)
Nonaminoglycoside compounds induce readthrough of nonsense mutations
Liutao Du et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Xeroderma pigmentosum group C in a French Caucasian patient with multiple melanoma and unusual long-term survival
S. Jacobelli et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Incidence of DNA repair deficiency disorders in western Europe: Xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy
Wim J. Kleijer et al.
DNA REPAIR (2008)
Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases
Mariana Hainrichson et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2008)
Influence of XPB helicase on recruitment and redistribution of nucleotide excision repair proteins at sites of UV-induced DNA damage
Kyu-Seon Oh et al.
DNA REPAIR (2007)
Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers
Samit Hirawat et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Aminoglycoside-induced translational read-through in disease: Overcoming nonsense mutations by pharmacogenetic therapy
L. V. Zingman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Aminoglycosides as potential pharmacogenetic agents in the treatment of Hailey-Hailey disease
Richard Kellermayer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Reduced XPC DNA repair gene mRNA levels in clinically normal parents of xeroderma pigmentosum patients
SG Khan et al.
CARCINOGENESIS (2006)
The UV-damaged DNA binding protein mediates efficient targeting of the nucleotide excision repair complex to UV-induced photo lesions
J Moser et al.
DNA REPAIR (2005)
Genetic factors in aminoglycoside toxicity
N Fischel-Ghodsian
PHARMACOGENOMICS (2005)
DNA-based diagnosis of xeroderma pigmentosum group C by whole-genome scan using single-nucleotide polymorphism microarray
CW Lam et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Readthrough of dystrophin stop codon mutations induced by aminoglycosides
MT Howard et al.
ANNALS OF NEUROLOGY (2004)
Two essential splice lariat branchpoint sequences in one intron in a xeroderma pigmentosum DNA repair gene:: mutations result in reduced XPC mRNA levels that correlate with cancer risk
SG Khan et al.
HUMAN MOLECULAR GENETICS (2004)
Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons
CH Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Versatility of Aminoglycosides and prospects for their future
SB Vakulenko et al.
CLINICAL MICROBIOLOGY REVIEWS (2003)
The total amount of DNA damage determines ultraviolet-radiation-induced cytotoxicity after uniform or localized irradiation of human cells
K Imoto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
The human XPC DNA repair gene:: arrangement, splice site information content and influence of a single nucleotide polymorphism in a splice acceptor site on alternative splicing and function
SG Khan et al.
NUCLEIC ACIDS RESEARCH (2002)
UV-induced DNA damage and repair: a review
RP Sinha et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2002)
A stop codon in xeroderma pigmentosum group C families in Turkey and Italy: Molecular genetic evidence for a common ancestor
EM Gozukara et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
Quantitation and visualization of ultraviolet-induced DNA damage using specific antibodies: Application to pigment cell biology
N Kobayashi et al.
PIGMENT CELL RESEARCH (2001)
Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system
M Manuvakhova et al.
RNA (2000)
The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6-4 photoproducts
S Emmert et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations
M Wilschanski et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
